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Abstract En bloc renal transplantation (EBT) from infant
donors is an option for children with end-stage renal
failure. Owing to potential complications, EBT is not
performed in all paediatric nephrology centres. We
evaluated the perioperative and long-term course of five
children undergoing EBT. Primary diagnosis was atypical
(diarrhoea-negative) haemolytic uraemic syndrome (n=2),
interstitial nephropathy (two siblings) and branchio-oto-
renal syndrome (n=1). Recipient and donor ages ranged
between 5.9 and 11.1 years and 0.3 and 2.5 years, re-
spectively. Follow-up time after EBT was 2.1–13.2 years.
Perioperative complications included (1) a renal artery
thrombosis, with immediate intraoperative reconstruction
and primary non-functioning of the graft, with recovery
after 10 days, and (2) a vesico-ureteric obstruction, suc-
cessfully managed with temporary insertion of a JJ-
catheter. All grafts had good long-term function. Absolute
glomerular filtration rate (GFR; millilitres/minute) in-
creased in all patients, whereas relative GFR (millilitres/
minute per 1.73 m2 body surface area) remained stable
during the follow-up period in all but one. Kidney size
increased significantly, with maximal growth during the
first year after EBT; magnetic resonance imaging (MRI)
showed normal structure and vasculature. EBT is a safe
and effective option for young children with end-stage
renal failure. Absolute GFR and graft size increase and
adapt to the children’s growing body mass.
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Introduction
Paediatric renal transplantation is the treatment of choice
for children with end-stage renal failure. The success of
this procedure has created an increasing shortage of donor
organs, as the number of potential kidney transplant re-
cipients has grown faster than the number of available
donor kidneys. This imbalance has led to expansion of the
criteria for the donor pool, including paediatric donors
under the age of 5 years. However, the use of kidney(s)
from young paediatric donors, transplanted as single-
kidney [1] or as infant en bloc transplantation (EBT) has
been controversial discussed [2, 3, 4, 5]. A high compli-
cation rate was reported after EBT in adult recipients, e.g.
graft thrombosis, urological problems and early rejection
[1, 2, 3], although graft survival and graft function were
favourable [4, 5, 6, 7, 8, 9]. This high complication rate
was observed not only in adults but also in the few pae-
diatric recipients undergoing EBT. Thus, the role of EBT
in paediatric recipients remained highly controversial [10,
11].
Kidneys from paediatric donors transplanted into the
growing child showed a better long-term functional ad-
aptation than did adult-donor kidneys [12, 13]. In contrast
to adult grafts, absolute glomerular filtration rate (GFR)
and kidney size increased in children receiving paediatric
grafts in relation to body growth [12, 13, 14, 15, 16].
We report on a small series of five children undergoing
EBT from young donors below the age of 30 months. All
grafts survived, and absolute GFR and kidney size in-
creased in relation to the growing body mass.
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Patients and methods
Since 1970, 132 children and adolescents below 20 years of age
have undergone transplantation at the University Children’s Hos-
pital in Zurich. Five of them underwent EBT between 1992 and
2003. Primary diagnosis was atypical (diarrhoea-negative)
haemolytic uraemic syndrome (n=2), familial interstitial nephrop-
athy (two siblings) and branchio-oto-renal syndrome (n=1). Re-
cipient and donor ages ranged from 5.9 to 11.1 years and 0.3 to 2.5
years, respectively. Informed consent was given by all parents.
Patients received triple immunosuppressive therapy: cyclospo-
rine A (aiming at a trough level of 180–250 ng/ml for the first 6
months and 80–120 ng/ml thereafter), azathioprine (1 mg/kg per
day) and prednisone, in patients A, B and C. Patients D and E were
given mycophenolate mofetil (1,200 mg/m2 body surface area per
day) instead of azathioprine. The initial prednisone dosage was
1 mg/kg per day, which was then tapered to alternate days after 6
months (5 mg/m2); prednisone was successfully withdrawn after 1
year in patients A, D and E.
All grafts were ABO compatible, and crossmatch was negative.
Patients A (A, B, DR) and B (A, DR) had three and two matches,
respectively; there was a complete HLA-mismatch in patients C, D
and E.
Surgical procedure in the donor was dissection of the suprarenal
aorta and inferior vena cava above the junction with the renal
vessels. The lower abdominal aorta and vena cava were removed en
bloc, together with the two kidneys, after ligation of the lumbar
vessels and the inferior mesenteric artery. Both the infrarenal aorta
and cava were closed by ligature two-to-three cm caudal to the
junction with the renal vessels. The suprarenal ends of the aorta and
cava were left open and used for end-to-side anastomosis to the
recipient’s arteria and vena iliaca in patients A, B and E and to the
recipient’s aorta and vena cava in patients C and D. Implantation of
the ureter was performed by an extravesical technique. In pa-
tients A, B and C a catheter was inserted transcutaneously between
pyelon and bladder, whereas a JJ-catheter was inserted between
pyelon and bladder in patients D and E. All catheters were removed
3 weeks after transplantation. Anticoagulation prophylaxis with
intravenously administered heparin (10 U/kg body weight per hour)
was started at the beginning of the operation and was continued for
14 days. Mannitolum (20%, 2 ml/kg body weight) was injected
during the anastomosis of donor’s and recipient’s vessels.
Estimated GFR was assessed either by the Schwartz formula or
Cr-EDTA clearance [17]. Kidney size and growth were measured
by ultrasound. In addition, repeated 24-h ambulatory blood pressure
measurement (24-h-ABPM) and magnetic resonance imaging
(MRI) with contrast-enhanced angiography (at the most recent
appointment in four patients) were performed. Anthropometric data
were compared with the norm for age and gender of Swiss children
[18].
Results
Perioperative course
Clinical data of donors and recipients are summarized in
Tables 1 and 2. The course of patient A was uneventful.
Patient B experienced renal artery thrombosis during the
operation, with immediate intraoperative reconstruction.
In spite of the young age of the recipient, 5.9 years, the
donor’s vessels had been anastomosed to the recipient’s
common iliac artery and vein. Because primary non-
functioning of the graft occurred, the immunosuppressive
treatment was switched on day 2 from cyclosporin A to
anti-thymocyte globulin (ATG, Fresenius, 3 mg/kg body
weight per day) for 10 days, resulting in full recovery of
renal function. In patient C, a JJ-catheter was inserted 2
months after EBT because of a vesico-ureteric obstruction
of the cranial ureter. Six months later the catheter was
removed, and drainage remained normal. Patients C, D
and E experienced a single episode of histologically
proven acute rejection 6 weeks, 3 weeks and 4 weeks after
EBT, respectively. Treatment consisted of six (patient C)
and three (patients D, E) methylprednisolone-pulses
(500 mg/m2 per day, intravenously) with renal function
(plasma creatinine) returning to baseline in all patients.
Table 1 Clinical data of recip-
ients and donors at EBT (m
male, f female, CIT cold isch-
aemia time)
Patient Age of donor CIT Age of recipient Height, cm Weight, kg
(gender) (months) (h) (years) (percentile) (percentile)
A (m) 24 26 9.1 133 (50) 31 (75)
B (f) 8 22 5.9 104 (<3) 16 (3)
C (m) 4 15 9.1 125 (3) 25 (10)
D (f) 20 18 5.9 106 (3) 16 (3)
E (f) 30 16 11.1 133 (10) 26 (3)
Table 2 Clinical follow-up data of recipients (1 year after EBT and most recent examination). GFR is in millilitres/minute per 1.73 m2. (m
male, f female)
Patient Follow-up Height, cm Weight, kg Casual blood pressure
on treatment
GFRa GFRa
(gender) (years) (percentile) (percentile) (mmHg) (Schwartz formula) (Cr-EDTA-clearance)
A (m) 1 144 (75) 38 (90) 128/80 71 Not done
13.2 192 (97) 91(>97) 138/82 51 28
B (f) 1 112 (3) 23 (50) 95/70 63 80
8.7 161 (25) 52 (50) 122/70 73 Not done
C (m) 1 131 (10) 29 (25) 112/78 78 83
7.1 175 (50) 72 (90) 120/63 76 Not done
D (f) 1 110 (3) 19 (10) 127/86 90 85
4.6 137 (10) 28 (10) 100/61 94 110
E (f) 1 142 (10) 35 (25) 116/78 86 Not done
2.1 154 (25) 41 (25) 107/61 89 106
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Long-term course
Long term follow-up times ranged from 2.1 years to 13.2
years. All patients had good graft function. Absolute GFR
(millilitres/minute) increased in all patients and reached
maximum level at the end of the adolescents’ linear
growth in patients A, B and C (Fig. 1a). Relative GFR
(millilitres/minute per 1.73 m2 body surface area) re-
mained stable during the follow-up period in patients B,
C, D and E (Fig. 1b). Relative GFR decreased in pa-
tient A, in accordance with his prominent body mass:
weight (91 kg), height (191 cm) and body surface area
(2.0 m2). Four patients were hypertensive, as assessed by
both casual blood pressure and 24-h-ABPM (mean arte-
rial blood pressure >95th percentile), and required anti-
hypertensive medication. None had proteinuria. Urinary
tract infection occurred in patients B, C and E; a voiding
cystogram revealed vesico-ureteric reflux in patient E.
Kidney size and growth
Maximal growth of the transplanted kidneys occurred
during the first year after EBT. The kidneys had reached
their maximum size at the end of linear growth in pa-
tients A, B and C. The most recent measurement of the
cranial and caudal kidneys showed normal size for age
and weight in patients A, B, D and E [19] (Fig. 2),
whereas the size of both kidneys was below the fifth
percentile in patient C [19]. MRI, performed in four pa-
tients, showed normal structure and vasculature in all
(data not shown).
Discussion
Our series of EBT in young paediatric recipients has
shown a favourable long-term outcome, demonstrating
Fig. 1 a Absolute GFR
(Schwartz formula) in millil-
itres/minute during the follow-
up period. Arrowheads final
height reached. b Relative GFR
(Schwartz formula) in millil-
itres/minute per 1.73 m2 body
surface area during the follow-
up period. Arrowheads final
height reached
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that EBT is an option not only for adult but also for
paediatric recipients.
The few perioperative vascular and urological com-
plications were successfully managed, with a minimum of
interventions. The anticoagulation therapy of patients
during and after renal transplantation might have con-
tributed to the favourable outcome. The intraperitoneal
positioning of the vascular anastomoses to the distal aorta
and inferior vena cava has been shown to be a feasible
and successful technique in children who receive a
transplant while less than 5 years of age [19]. In children
undergoing EBT this procedure needs also to be consid-
ered in older children, as patient B sustained an intraop-
erative renal arterial thrombosis at the age of 5.9 years.
The large diameters of the distal aorta and inferior vena
cava, compared to those of the iliacal vessels, might
prevent technical failures and subsequent graft thrombo-
sis. In addition, repeated ultrasound imaging is required
after EBT to focus on ureteric dilatation secondary to
vesico-ureteric obstruction.
Absolute GFR increased in relation to body growth in
all recipients, resulting in a stable relative GFR. Consis-
tent with absolute GFR, kidney size increased after EBT,
and growth rate was highest during the first year after
EBT. The most recent size of nine out of ten kidneys was
normal compared with that of age-related healthy controls
Fig. 2 a Length (centimetres) of cranial kidney during the follow-up period. Arrowheads final height reached. b Length (centimetres) of
caudal kidney during the follow-up period. Arrowheads final height reached
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[20]. In particular, five out of the six kidneys of the three
patients who had reached final linear growth were also
normal for age and body size [20]. These observations are
consistent with other studies confirming that kidney(s)
from paediatric donors have the potential to increase
glomerular function in relation to body growth and
therefore to adapt to the growing child [12, 13, 14, 15,
16]. In contrast, adult-donor kidneys transplanted into
children down-regulate their glomerular function imme-
diately in the perioperative period in relation to body size
of paediatric recipients and lack the capacity to increase
its function according to subsequent body growth in
children [12, 13]. These results confirm the notion that
kidney(s) from paediatric donors should be allocated with
higher priority to paediatric recipients [21].
In summary, en bloc renal transplantation from infant
donors was a safe and effective option for young children
with end-stage renal failure. Absolute GFR and kidney
size adapted to increasing size and body mass of growing
children, leading to excellent long-term function.
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